Sterling Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $810K | Buy |
33,636
+10,615
| +46% | +$278K | 0.01% | 625 |
|
|
2026
Q1 | $646K | Sell |
23,021
-156
| -0.7% | -$4.15K | 0.01% | 654 |
|
|
2025
Q4 | $577K | Sell |
23,177
-216,429
| -90% | -$5.46M | 0.01% | 871 |
|
|
2025
Q3 | $6.11M | Buy |
239,606
+153,239
| +177% | +$3.78M | 0.09% | 152 |
|
|
2025
Q2 | $2.09M | Sell |
86,367
-54,579
| -39% | -$1.27M | 0.03% | 379 |
|
|
2025
Q1 | $3.57M | Buy |
140,946
+8,650
| +7% | +$226K | 0.06% | 233 |
|
|
2024
Q4 | $3.51M | Sell |
132,296
-8,745
| -6% | -$237K | 0.05% | 278 |
|
|
2024
Q3 | $4.08M | Buy |
+141,041
| New | +$4.11M | 0.05% | 255 |
|
|
2019
Q3 | $45.4M | Sell |
1,330,539
-149,579
| -10% | -$5.44M | 0.43% | 89 |
|
|
2019
Q2 | $60.8M | Buy |
1,480,118
+13,108
| +0.9% | +$521K | 0.59% | 66 |
|
|
2019
Q1 | $59.1M | Sell |
1,467,010
-472,421
| -24% | -$18.9M | 0.58% | 67 |
|
|
2018
Q4 | $80.3M | Sell |
1,939,431
-448,308
| -19% | -$18.6M | 0.87% | 27 |
|
|
2018
Q3 | $99.8M | Sell |
2,387,739
-224,967
| -9% | -$8.66M | 0.9% | 20 |
|
|
2018
Q2 | $89.9M | Buy |
2,612,706
+372,286
| +17% | +$12.7M | 0.84% | 30 |
|
|
2018
Q1 | $75.4M | Buy |
2,240,420
+110,560
| +5% | +$3.8M | 0.71% | 52 |
|
|
2017
Q4 | $73.2M | Sell |
2,129,860
-36,299
| -2% | -$1.24M | 0.66% | 52 |
|
|
2017
Q3 | $73.4M | Sell |
2,166,159
-61,798
| -3% | -$1.99M | 0.69% | 51 |
|
|
2017
Q2 | $71M | Sell |
2,227,957
-69,103
| -3% | -$2.18M | 0.69% | 48 |
|
|
2017
Q1 | $74.6M | Sell |
2,297,060
-333,501
| -13% | -$10.5M | 0.7% | 42 |
|
|
2016
Q4 | $81.1M | Sell |
2,630,561
-459,411
| -15% | -$14M | 0.73% | 47 |
|
|
2016
Q3 | $99.3M | Sell |
3,089,972
-27,008
| -0.9% | -$903K | 0.91% | 31 |
|
|
2016
Q2 | $104M | Buy |
3,116,980
+384,552
| +14% | +$12.3M | 0.95% | 19 |
|
|
2016
Q1 | $76.8M | Sell |
2,732,428
-694,579
| -20% | -$19.8M | 0.7% | 53 |
|
|
2015
Q4 | $105M | Sell |
3,427,007
-132,858
| -4% | -$4.18M | 0.93% | 21 |
|
|
2015
Q3 | $106M | Sell |
3,559,865
-77,614
| -2% | -$2.49M | 0.95% | 22 |
|
|
2015
Q2 | $116M | Sell |
3,637,479
-66,726
| -2% | -$2.17M | 1.04% | 22 |
|
|
2015
Q1 | $122M | Buy |
3,704,205
+51,351
| +1% | +$1.63M | 1.09% | 22 |
|
|
2014
Q4 | $108M | Buy |
3,652,854
+1,501,420
| +70% | +$43.1M | 0.94% | 31 |
|
|
2014
Q3 | $60.4M | Sell |
2,151,434
-1,565,981
| -42% | -$44M | 0.73% | 38 |
|
|
2014
Q2 | $105M | Sell |
3,717,415
-206,728
| -5% | -$5.89M | 0.9% | 36 |
|
|
2014
Q1 | $120M | Buy |
3,924,143
+89,171
| +2% | +$2.66M | 1.02% | 30 |
|
|
2013
Q4 | $111M | Buy |
3,834,972
+168,368
| +5% | +$4.9M | 1.02% | 32 |
|
|
2013
Q3 | $99.9M | Sell |
3,666,604
-112,262
| -3% | -$3.05M | 1.17% | 26 |
|
|
2013
Q2 | $100M | Buy |
+3,778,866
| New | +$104M | 1.23% | 26 |
|
Other funds holding PFE
Sterling Capital Management's PFE Position: Q2 2026 in Review
Sterling Capital Management increased its Pfizer (PFE) stake by 46% in Q2 2026, buying an estimated $278K and bringing the position to 33,636 shares worth $810K. The position accounts for 0.01% of the portfolio, ranked #625.
Sterling Capital Management first reported a position in PFE in Q2 2013 and has held it in 34 quarters since. The position peaked at $122M in Q1 2015. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Sterling Capital Management held 33,636 shares of Pfizer worth $810K as of Q2 2026.
- Sterling Capital Management bought 10,615 Pfizer shares in Q2 2026, an estimated $278K.
- Pfizer made up 0.01% of Sterling Capital Management's portfolio in Q2 2026, its #625 holding.
- Sterling Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 34 quarters since.
- Sterling Capital Management's Pfizer position peaked at $122M in Q1 2015.
- 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.